You are here: Industry Insights > aspirin

News List

Aspirin is linked with increased risk of heart failure WorldPharmaNews
November 24, 2021
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
No survival benefit from aspirin in COVID-19 patients pharmatimes
June 10, 2021
Findings of the UK RECOVERY trial show that use of aspirin in the hope of reducing blood clotting in patients hospitalised with COVID-19 does not have any impact on survival.
Aspirin may decrease ICU admission and death in COVID-19 patients europeanpharmaceuticalreview
March 18, 2021
In a new study, low dose aspirin reduced risk of mechanical ventilation, ICU admission and in-hospital mortality by over 40 percent each.
Granules India gets USFDA approval for OTC Acetaminophen, Aspirin and Caffeine Tablets expresspharma
February 25, 2021
Granules India announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC).
UK study will evaluate aspirin as a potential COVID-19 treatment pharmatimes
November 11, 2020
Researchers from the UK’s RECOVERY study will evaluate the standard painkiller aspirin as a potential treatment for COVID-19 patients.
Trial in Britain to assess aspirin as potential COVID-19 drug expresspharma
November 09, 2020
The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would include the drug, which is commonly used as a blood thinner.
Aspirin could protect patients from severe COVID-19 complications europeanpharmaceuticalreview
October 26, 2020
A study has shown that aspirin use was associated with a 47 percent decrease in the risk of dying in the hospital from COVID-19.
US priority review for AZ' Brilinta/aspirin combination pharmatimes
July 14, 2020
The US Food and Drug Administration has agreed to a speedy review of AstraZeneca's Brilinta (ticagrelor) for the reduction of subsequent stroke in patients who have experienced an acute ischaemic stroke or transient ischaemic attack (TIA).
Regular dose of aspirin can lower risk of inherited bowel cancer: Study expresspharma
June 15, 2020
The research, carried out by Universities of Newcastle and Leeds, and funded by Cancer Research UK, NIHR, Bayer Pharma AG and the Barbour Foundation ...
Low-dose aspirin linked to reduced liver cancer risk worldpharmanews
March 13, 2020
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes.